₹349.00
-11.50 (-3.19%)
As of 9 Oct 2026, Biocon Ltd share price is ₹349.00. The stock opened at ₹349.00 and had closed at ₹360.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹337.95 and a high of ₹447.00. In terms of performance, Biocon Ltd share price has increased by 1.17% over the past six months and has decreased by 1.11% over the last year.
BIOCON Stock Price Chart
Biocon Ltd Overview
Market cap₹58,750 Crs
Volume1,43,591
Prev. Close₹360.50
Year range₹337.95 - ₹447.00
ISININE376G01013
About BIOCON
Biocon is engaged in the manufacture of biotechnology products and research services. The Company
Biocon Ltd Historical Performance
1 Month Return-11.09%
6 Month Return-0.29%
3 Year Return33.95%
3 Month Return-12.07%
1 Year Return0.09%
5 Year Return-3.07%
BIOCON Futures & Options
Biocon Ltd Fundamentals
ROCE(TTM)1.44%
P/E Ratio (TTM)600.83
P/B Ratio2.15
Debt to Equity0.04
ROE0.88%
EPS (TTM)1.85
Dividend Yield0.14%
Book Value167.99
Profit Margin12.38%
Operating Margin5.09%
Biocon Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,666.10 | 2,484.90 | 2,320.30 | 2,264.30 | 1,925.40 |
| EBITDA | 330.70 | 1,025.60 | 470.20 | 3,157.70 | 248.30 |
| Net Profit | 37.20 | 609.30 | 119.30 | 2,848.40 | 86.10 |
| EPS | 0.27 | 5.09 | 1.00 | 23.87 | 0.72 |
Biocon Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 355.95 |
| Resistance 1 (R1) | 367.50 |
| Pivot Point | 362.95 |
Biocon Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 03-Jul-2026 | 07-May-2026 | 03-Jul-2026 | Final | ₹0.50 |
| 04-Jul-2025 | 08-May-2025 | 04-Jul-2025 | Final | ₹0.50 |
| 05-Jul-2024 | 16-May-2024 | 05-Jul-2024 | Final | ₹0.50 |
| 07-Jul-2023 | 23-May-2023 | 07-Jul-2023 | Final | ₹1.50 |
| 30-Jun-2022 | 28-Apr-2022 | 01-Jul-2022 | Final | ₹0.50 |
BIOCON Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Kiran Mazumdar Shaw | Chairperson |
| Ravi Mazumdar | Non Executive Independent Director |
| Eric Vivek Mazumdar | Non Executive Independent Director |
Biocon Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,759.80-1.19% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,361.00-2.37% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,617.10-2.10% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Biocon Ltd today is ₹349.00 on NSE and ₹349.00 on BSE.
- The 52-week high of Biocon Ltd is ₹447.00, while the 52-week low is ₹337.95.
- The current market capitalisation of Biocon Ltd is approximately ₹58,750 crore.
- The P/E (Price-to-Earnings) ratio of Biocon Ltd is 97.49. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Biocon Ltd is 1.62. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Biocon Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BIOCON on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Biocon Ltd has delivered a return of approximately 33.95%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Biocon Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 44.68% promoters, -7.33% FIIs, 23.38% DIIs, and 10.26% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
